🔴 Quantum BioPharma is trading 5% down with no clear company-specific catalyst

Quantum BioPharma is trading 5.48% lower at $2.73 on October 14, 2026; no clear company-specific catalyst has been identified.

• The summit announcement circulating in search results was originally issued September 15; the Thermo Fisher trial agreement was announced October 6.
• Hotter-than-expected September inflation revived rate-hike concerns and pressured U.S. equities. Reuters reported indexes lower after the release, although healthcare was among the sectors rising.
• A direct market explanation for Quantum BioPharma’s decline is not established.